Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




End Points of Therapy in Chronic Hepatitis B
Link ID 23073
Title End Points of Therapy in Chronic Hepatitis B
Url http://www.medscape.com/viewarticle/717070?src=rss
Description What clinical, histological, biochemical and virological end points of antiviral therapy in chronic hepatitis B are most relevant? Expert Review of Gastroenterology and Hepatology
Category Articles > Gastroenterology
Keywords
Date Mar 9, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Gastroenterology
1. Mepolizumab Has No Clinical Impact on Eosinophilic Esophagitis
  Treatment with mepolizumab, a humanized anti-interleukin-5 monoclonal antibody, does not have a major effect in adults with active eosinophilic esophagitis, researchers report in the January issue of Gut. Reuters Health Information
Category:   Articles > Gastroenterology


2. Multipolar Radiofrequency Ablation Yields High Liver Cancer Survival Rates
  Patients with metastatic hepatocellular carcinoma (HCC) who receive multipolar radiofrequency ablation, delivered to multiple sites simultaneously, have very high tumor eradication rates. They also have survival rates similar to patients who undergo surgery after a mean of nearly 2 years of follow-up, investigators announced in Washington, DC, at the annual meeting of the American Roentgen Ray Society meeting. Reuters Health Information
Category:   Articles > Gastroenterology


3. Twelve-Week Protease-Based Triple Therapy Results in High HCV Cure Rates
  Telaprevir added to standard therapy boosts virologic response by 50%, and cure rates occur within 12 weeks. Medscape Medical News
Category:   Articles > Gastroenterology


4. Smaller Pancreatic Tumors Have Dramatically Better Prognosis
  Patients with pancreatic cancer diagnosed when the tumor is 20 mm or less have a dramatically better prognosis than those whose tumors are larger; unfortunately, few pancreatic tumors are found when they are still this small. Medscape Medical News
Category:   Articles > Gastroenterology


5. Fidaxomicin: A New Macrocyclic, RNA Polymerase-Inhibiting Antibiotic for the Treatment of Clostridiu
  Fidaxomicin has shown considerable promise in treating Clostridium difficile infection and preventing relapses. Future Virology
Category:   Articles > Gastroenterology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS